Biotechnology recruiting is hot. It''s more active than IT and telecommunications and it isn''t suffering the shortages in other areas of healthcare, says Frank Heasley, PhD, President and CEO, of ...
Fintel reports that on August 15, 2023, Morgan Stanley maintained coverage of IO Biotech (NASDAQ:IOBT) with a Overweight recommendation. As of August 2, 2023, the average one-year price target for IO ...
Fintel reports that on August 11, 2023, HC Wainwright & Co. reiterated coverage of IO Biotech (NASDAQ:IOBT) with a Buy recommendation. As of August 2, 2023, the average one-year price target for IO ...
Hosted on MSN
Raymond James Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation
Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform recommendation. Analyst Price Forecast Suggests 232.11% Upside As of June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results